While I think the results are very positive.. I will not sit here and jump up and down until we get a better understanding of expected cash outflows from developing and enhancing what is in the pipeline. Given the situiation that we are in, I wish they would give context around the numbers.. that is, how many generics Axiron is now competing against (if any).
